🔎 Tricuspid Regurgitation in Heart Failure: when is it time to act? When should we suspect TR progression? When should we worry about right-heart deterioration? And when should we refer or intervene? Join the upcoming live webinar in collaboration with @PCRonline Tricuspid Focus Group for an expert discussion. 📅 Thursday 3 September I 5:00 PM (UTC+2) 💻 Online I Free 👉 Register now: pcronline.com/Webinars/PCR-W… @MariannaAdamo1 @masitges @GMCRosano #HeartFailure #TricuspidRegurgitation #Cardiology #CardioEducation #CardioTwitter

NEW PRE-COURSE | Cardiogenic shock: "Eyes on the pump" 🫀 Join the iHF & PCR MCS Focus Group on 21 November in London, ahead of #PCRLondonValves. A focused, interactive Programme on MCS decision-making, device selection, complications, escalation & weaning. Discover more → pcronline.com/Network/Pre-co… @PCRonline @AlexMebazaa @EmanueleBarba13 @SabineBleiziff2 @FlavioRibichini #CardiogenicShock #MCS

Recognising coronary microvascular dysfunction in #HFpEF is only the first step. Explore diagnosis, patient selection and the evidence informing tailored treatment during this free live iHF Webinar. 📅 29 September, 5:30pm (UTC+2) 🔗 iheartfunction.com/webinars/…

TR in heart failure: when to suspect, when to worry, when to act? Join our webinar with the PCR Tricuspid Focus Group, featuring @MariannaAdamo1, @masitges, @GMCRosano, Marina Urena & Mirjam Wild. 📅 Thursday 3 September | 5:00 PM UTC+2 Register now: brnw.ch/21x5feQ @pcr_online #Cardiology #HeartFailure #CardioTwitter

🔎Do you remember the case of the 39-year-old patient with a late #STEMI complicated by severe biventricular dysfunction and a ventricular septal rupture requiring emergent VA-ECMO and IABP support? The poll sparked a wide range of opinions - highlighting just how challenging these cases can be. 🫀Now discover how the Heart Team approached this complex mechanical complication, balancing timing, hemodynamic support, and definitive treatment. 📖Read Part 2: iheartfunction.com/cases-res… #HeartFailure #Cardiology #STEMI #HeartTeam #MedicalEducation #CardioEd

🫀 New Trial Review: the SUBCUT HF II Presented at #HFA 2026, the SUBCUT-HF II trial explores whether early discharge with an ambulatory subcutaneous furosemide pump could transform heart failure care. In this Trial Review, @JanBiegus examines the evidence behind this innovative home-based decongestion strategy. 🎥 Watch the full review: iheartfunction.com/news/subc… #HeartFailure #Cardiology #ClinicalTrials #CardioEd #Cardiology #CardioEducation

🎥Missed our latest iHF webinar? The replay is now available! Join a multidisciplinary Heart Team discussion on managing patients with HFrEF & chronic coronary syndromes through a real-world case. 🔗 iheartfunction.com/webinars/… Key topics: - Patient selection for revascularisation - PCI vs CABG - GDMT optimisation after revascularisation #HeartFailure #Cardiology #HeartTeam #GDMT #CardioEd #CardioTwitter

🫀Can ARNI therapy improve outcomes in patients with #HFpEF and atrial functional mitral regurgitation? In this new Journal Club, @Jolie_Bruno_ reviews the PRAISE-MR trial published in Circulation and discusses its potential implications for clinical practice. Read here: iheartfunction.com/news/angi… #HeartFailure #Cardiology #JournalClub #ARNI #HFpEF

🫀Post-MI ventricular septal rupture: a critical trans-disciplinary case A 39-year-old patient with no medical history developed a non-restrictive VSD, severe biventricular dysfunction, and cardiogenic shock following a late #STEMI. Despite #PCI and IABP support, he deteriorated and required VA-ECMO. 👀How would you manage this mechanical complication? 👉 Read the case and vote here: iheartfunction.com/cases-res… @EchoSoliman @BarilliMaria #HeartFailure #CardiogenicShock #ECMO #VentricularSeptalRupture #CardioEd #CardioTwitter

🎥How can #GDMT and #MCS devices optimize the management of patients with advanced heart failure? Daniel Burkhoff and @AlexMebazaa share key insights from a #EuroPCR 2026 case-based session covering hemodynamic monitoring, short-term MCS, patient stabilization, GDMT optimization, and advanced therapy pathways. ▶️ Watch the full replay: brnw.ch/21x3si4 #AdvancedHeartFailure #HeartFailure #GDMT #Cardiology #CardioEd

⏳Live webinar today: one hour that could change your approach to #HFrEF and #CCS! 📆 19 June 2026 I 5:30pm (UTC+2) 👉Register now: iheartfunction.com/webinars/… Join a discussion with renowned experts to learn more about patient selection for revascularisation, optimal treatment strategies, and the latest developments in GDMT following intervention. @MartineGilard @drbennisahmed @ARakisheva @SabineBleiziff2 @emilianofiorimd @belmontemarta1 #CardioEd #Cardiology #HeartFailure

👀@AlexMebazaa has a message for you... Join us on Friday for an #iHF webinar and discover the latest advances in optimising care for patients with #HFrEF and #CCS, presented by a trans-disciplinary team of experts. 📆 June 19 I 17:30 (UCT+2) 👉 Register now: iheartfunction.com/webinars/… @SabineBleiziff2 @drbennisahmed @emilianofiorimd @MartineGilard @ARakisheva @belmontemarta1 #CardioEd #MedicalEducation #HeartFailure

⏳Only 3 days until our next #iHF Webinar! Which patients with #HFrEF and CAD should undergo revascularisation? What is the best strategy? And how should GDMT be optimised afterwards? Join our upcoming webinar and discuss these key questions with leading experts! 👉Register now: iheartfunction.com/webinars/… #CardioEd #Cardiology @MartineGilard @ARakisheva @drbennisahmed @SabineBleiziff2 @emilianofiorimd @belmontemarta1

🫀 When is "early" truly early in mitral regurgitation? @AlexMebazaa and @SabineBleiziff2 discuss the optimal timing for mitral valve repair and why timely intervention matters for patient outcomes. Watch the full #iHFCourse2026 session: iheartfunction.com/cases-res… @EmanueleBarba13 @PhilippLurz @Jolie_Bruno_ @ARakisheva #Cardiology #HeartFailure #MitralRegurgitation

🫀 How do we optimise care pathways for patients with HFrEF and chronic coronary syndromes in contemporary practice? 📆 Next iHF Webinar: Wednesday 19 June 2026 at 5:30pm (UTC+2) Join leading international experts for an in-depth discussion on: iheartfunction.com/webinars/…

Privileged to be part of this discussion alongside outstanding speakers and discussants. Interested in advancing the care of patients with CAD and HFrEF? Join us as we come together to share knowledge, exchange experiences, and discuss the latest perspectives in patient care.🌍🤍

🫀 New iHF Webinar: “HFrEF & Chronic Coronary Syndromes: from guideline-directed medical therapy to optimal revascularisation strategy” 📅 19 June 2026 | ⏰ 17:30 CET (UTC+2) 👉 Register here: iheartfunction.com/webinars/… Join international experts to explore GDMT optimisation, revascularisation strategies and multidisciplinary decision-making in complex HF patients. Speakers: @SabineBleiziff2 @MartineGilard @ARakisheva @drbennisahmed @emilianofiorimd Nadya Al Matrooshi #HFrEF #HeartFailure #Cardiology #GDMT #CardioTwitter #InterventionalCardiology #iHF

Merci beaucoup🙏to everyone who joined us for 4 incredible days of learning & sharing at #EuroPCR, in Paris, and via the Course platform Thank you to the Course Directors, faculty, LIVE centres, presenters, participants, industry partners, support & AV teams, staff and @ViparisOfficiel - safe travels back home ✈️🚂🚋🚓🚴‍♂️ We are convinced - as you are - that education saves lives, so please mark your calendars for the next edition: 18-21 May 2027. #interventionalcardiology #KeepOnLearning #Science #Research #CardioEd

🔥#EuroPCR 2026 has started - and we’re excited to hear the latest on heart failure! Members of the iHF Steering Committee and transdisciplinary team will take part in key sessions, sharing their expertise across a wide spectrum of cardiovascular topics. Full line-up here: brnw.ch/21x2soF #Cardiology #HeartFailure #CardioEd @AlexMebazaa @EmanueleBarba13

𝗶𝗛𝗙 at #EuroPCR 2026! Join us for the session: “When to best combine guideline-directed medical therapy and devices at discharge of acute heart failure” 📅 Wed 20 May | 9:45–10:45 📍 Room 243 With @AlexMebazaa, @VranckxPascal and expert discussants, we’ll explore GDMT, CRT, and the benefits of combining therapies and devices at discharge in acute heart failure. Looking forward to seeing many of you there! Learn more: brnw.ch/21x2wfL #Cardiology #HeartFailure